Aug. 8, 2007 â Atropine (Atropisol) may be a good alternative to patching for the noncompliant mortal with amblyopia, according to the results of a randomized endeavour published in the August yield of Ophthalmology .
Patching for more than 10 period of time initially had a more rapid visual aspect, but by six months, atropine was about as effective as patching regardless of time.
“Our findings are important because previous retrospective case studies suggested atropine might be less effective than patching, and that it was largely ineffective in children with poorer visual visual sense,” lead expert Michael X.
Repka, MD, from Johns INSTANCE OFbiochemist Establishment in Baltimore, Maryland, says in a news accomplishment. “However, our memorizer found atropine was just as effective when visual keenness in the poor eye was 20/100, as it was when keenness was 20/40.
These inception findings suggest the need for a time written report, in which we will assess the event of atropine at visual visual sense levels worse than 20/100.”
This reflection enrolled 1,419 children younger than VII age of age from 47 U.S. clinical sites, randomized them to aid with patching or with 1% atropine drops in the strong eye, and followed them for six months.
Initial visual visual acuity ranged from 20/40 to 20/100.
At kickoff, the betterment in visual intelligence in the amblyopic eye was slightly greater in the patched radical than in the atropine chemical group.
The congeneric tending result did not vary with age, justification of amblyopia, or line amblyopic visual keenness.
Patients with visual modality levels of 20/80 to 20/100 improved faster with 10 or more work time of patching daily than with fewer hour of patching daily ( P = .01) or with atropine ( P < .001).
By six months, these differences were not significant.
This is a part of article Atropine May Be a Good Alternative to Patching. Taken from "Atropisol - Atropine Information" Information Blog
Friends
Wednesday, October 10, 2007
Atropine May Be a Good Alternative to Patching.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment